Panagora Asset Management Inc Corcept Therapeutics Inc Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $397,290 - $580,002	-22,925 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$17.1 - $23.34 $205,901 - $281,036	-12,041 Reduced 34.44%	22,925 $454,000
Q2 2021 Aug 11, 2021	SELL	$19.97 - $24.43 $5.2 Million - $6.36 Million	-260,503 Reduced 88.17%	34,966 $769,000
Q1 2021 May 12, 2021	SELL	$23.49 - $30.56 $1.61 Million - $2.09 Million	-68,519 Reduced 18.82%	295,469 $7.03 Million
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $950,486 - $1.55 Million	-56,644 Reduced 13.47%	363,988 $9.52 Million
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $3.23 Million - $5.18 Million	259,433 Added 160.94%	420,632 $7.32 Million
Q2 2020 Aug 12, 2020	BUY	$11.0 - $18.26 $1.3 Million - $2.16 Million	118,514 Added 277.65%	161,199 $2.71 Million
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $444,350 - $625,762	42,685 New	42,685 $603,000

349

85.5M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.